Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Generation Bio Co. (GBIO)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 59,420,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Generation Bio is a genetic medicines company providing durable, redosable treatments for potentially various of patients living with rare and prevalent diseases. Co.'s non-viral genetic medicine platform incorporates its DNA construct called closed-ended DNA; its cell-targeted lipid nanoparticle delivery system; and its capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, to produce ceDNA. Using Co.'s platform, it is developing genetic medicines to provide targeted delivery of genetic payloads that include large and multiple genes to a range of cell types across a range of diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 551,455 551,455 642,217
Total Buy Value $0 $778,895 $778,895 $1,265,385
Total People Bought 0 4 4 4
Total Buy Transactions 0 7 7 12
Total Shares Sold 0 4,890 11,122 27,899
Total Sell Value $0 $7,922 $39,768 $125,583
Total People Sold 0 2 2 2
Total Sell Transactions 0 2 4 10
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 293
  Page 9 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Zimmermann Tracy CHIEF DEVELOPMENT OFFICER   •       –      –    2021-04-22 4 AS $33.32 $83,300 D/D (2,500) 0     -
   Zimmermann Tracy CHIEF DEVELOPMENT OFFICER   •       –      –    2021-04-22 4 OE $4.59 $11,475 D/D 2,500 2,500     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-04-22 4 AS $34.03 $51,045 D/D (1,500) 198,154     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-04-22 4 OE $0.60 $900 D/D 1,500 199,654     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-04-21 4 AS $31.07 $46,605 D/D (1,500) 198,154     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-04-21 4 OE $0.60 $900 D/D 1,500 199,654     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-04-16 4 AS $28.03 $42,045 D/D (1,500) 198,154     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-04-16 4 OE $0.60 $900 D/D 1,500 199,654     -
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2021-04-14 4 AS $26.40 $622,995 D/D (23,413) 0     -
   Rhodes Jason P Director   –       •      –    2021-04-14 4 AS $26.40 $622,995 I/I (23,413) 0     -
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2021-04-13 4 AS $25.09 $1,085,744 D/D (43,145) 23,413     -
   Rhodes Jason P Director   –       •      –    2021-04-13 4 AS $25.09 $1,085,744 I/I (43,145) 23,413     -
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2021-04-12 4 AS $26.07 $1,938,229 D/D (74,124) 66,558     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-04-12 4 AS $26.12 $157,446 D/D (6,000) 198,154     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-04-12 4 OE $0.60 $3,600 D/D 6,000 204,154     -
   Rhodes Jason P Director   –       •      –    2021-04-12 4 AS $26.07 $1,938,229 I/I (74,124) 66,558     -
   Rhodes Jason P Director   –       •      –    2021-04-09 4 AS $27.57 $1,205,948 I/I (43,681) 140,682     -
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2021-04-09 4 AS $27.57 $1,205,948 D/D (43,681) 140,682     -
   Rhodes Jason P Director   –       •      –    2021-04-08 4 AS $28.47 $1,241,241 I/I (43,550) 184,363     -
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2021-04-08 4 AS $28.47 $1,241,241 D/D (43,550) 184,363     -
   Rhodes Jason P Director   –       •      –    2021-04-07 4 AS $28.48 $1,136,671 I/I (39,864) 227,913     -
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2021-04-07 4 AS $28.48 $1,136,671 D/D (39,864) 227,913     -
   Kerr Douglas CHIEF MEDICAL OFFICER   •       –      –    2021-04-05 4 AS $29.91 $423,451 D/D (14,072) 326,558     -
   Kerr Douglas CHIEF MEDICAL OFFICER   •       –      –    2021-04-05 4 OE $5.16 $72,612 D/D 14,072 340,630     -
   Atlas Venture Fund X, L.p. 10% Owner   –       –       •   2021-03-16 4 AS $0.00 $0 D/D (1,000,000) 9,111,939     -
  293 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us